Search - tctmd.com

Displaying 661 - 675 of 675

Sort: Relevancy | Date

News Daily News

ACCOAST Analysis Identifies Factors Tied to Higher Bleeding Risks in NSTE-ACS

Todd Neale

June 22, 2015

News Daily News

Event Rates Often Overestimated in Cardiovascular Trials

Yael L. Maxwell

June 10, 2015

News Industry News

Global Cardiovascular Drug Delivery Market 2015 - Technologies, Markets and Companies

May 28, 2015

News Industry News

CVRx® Barostim Therapy® for Heart Failure Clinical Trial Results Presented in the Late-Breaking Clinical Trial Session of the Heart Rhythm Society 2015 Annual Conference

May 26, 2015

News Daily News

Low Trial Participation Rate of MI Patients Raises Questions of Applicability

Todd Neale

September 02, 2014

News Conference News TCT 2013

Innovation in Intervention: Perspectives from Industry

October 30, 2013

News Conference News AHA 2012

AHA 2012: Multiple Studies Provide Clinical Guidance for Interventional Community

Jason Kahn

November 11, 2012

Presentation TCT 2012

A 42-Year-Old Female with True Severe Resistant Hypertension

Presenter: Konstantinos Tsioufis

October 25, 2012

News Daily News

Un Modelo Sugiere que la Denervación Renal es Rentable contra la Hipertensión Resistente

September 13, 2012

News Daily News

Model Suggests Renal Denervation Cost-effective for Resistant Hypertension

September 13, 2012

News Conference News ACC 2012

Color Coding, Checklists Improve Use of Evidence-Based Strategies for ACS

L.A. McKeown

March 25, 2012

News Daily News

Low US Participation in NIH-Sponsored CVD Trials Cause for Concern

Jason Kahn

August 01, 2011

News Daily News

Study Finds All-Comers Design Not So All Inclusive

Caitlin E. Cox

June 15, 2011

News Daily News

Dabigatran Cost-Effective Only for A-Fib Patients at High Stroke Risk

L.A. McKeown

June 03, 2011

News Daily News

Insurance Type Affects Outcomes After PCI

L.A. McKeown

January 06, 2011

Advertisement

ACCOAST Analysis Identifies Factors Tied to Higher Bleeding Risks in NSTE-ACS

Event Rates Often Overestimated in Cardiovascular Trials

Global Cardiovascular Drug Delivery Market 2015 - Technologies, Markets and Companies

CVRx® Barostim Therapy® for Heart Failure Clinical Trial Results Presented in the Late-Breaking Clinical Trial Session of the Heart Rhythm Society 2015 Annual Conference

Low Trial Participation Rate of MI Patients Raises Questions of Applicability

Innovation in Intervention: Perspectives from Industry

AHA 2012: Multiple Studies Provide Clinical Guidance for Interventional Community

A 42-Year-Old Female with True Severe Resistant Hypertension

Un Modelo Sugiere que la Denervación Renal es Rentable contra la Hipertensión Resistente

Model Suggests Renal Denervation Cost-effective for Resistant Hypertension

Color Coding, Checklists Improve Use of Evidence-Based Strategies for ACS

Low US Participation in NIH-Sponsored CVD Trials Cause for Concern

Study Finds All-Comers Design Not So All Inclusive

Dabigatran Cost-Effective Only for A-Fib Patients at High Stroke Risk

Insurance Type Affects Outcomes After PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content